About Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP
Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, is president and director, Scientific and Clinical Affairs Remitigate LLC, and a clinical pharmacy specialist at the Stratton Veterans Affairs (VA) Medical Center in Albany, New York.
He is an adjunct associate professor of Pharmacy Practice at Western New England University College of Pharmacy; adjunct associate professor of Pharmacy Practice at Albany College of Pharmacy; adjunct assistant professor of Pharmacy Practice at the University of Connecticut School of Pharmacy. He is a diplomate of the Academy of Integrative Pain Management (AIPM), and a fellow of the American College of Clinical Pharmacy (ACCP) and the American Society of Health-system Pharmacists (ASHP).
Dr. Fudin is a section editor for Pain Medicine, the official journal of AIPM. He is Founder/Chairman of Professionals for Rational Opioid Monitoring & Pharmacotherapy (PROMPT), a group that advocates in favor of safe opioid prescribing by encouraging clinician education, proactive risk stratification, and appropriate therapeutic monitoring.
Dr. Fudin graduated from the Albany College of Pharmacy & Health Sciences with his Bachelors Degree and his PharmD. He was awarded and completed an American Cancer Society Sponsored Fellowship in Oncology/Hematology at SUNY/Upstate Medical Center shortly after his undergraduate work. He has been an Instructor of Pharmacology at SAGE Graduate School of Nursing for several years. He is a Clinical Pharmacy Consultant to Homedical Associates, an innovative home-based academic patient care service dedicated to treating medically complex patients in their homes.
As a peer reviewer, Dr. Fudin helped to establish the American Pain Society (APS) Clinical Practice Guidelines for Arthritis, for Fibromyalgia, and for Cancer Pain and Palliative Care. He was a panel member for establishing guidelines on the “Use of Chronic Opioids for Chronic Non-Cancer Pain,” a collaborative effort between the APS and the American Academy of Pain Medicine (AAPM); these guidelines have been widely disseminated by the American Journal of Pain for use by healthcare providers worldwide. Recently, he participated in development of draft guidelines for the proper use of urine testing in addiction medicine, a collaborative project by the National Association of Addiction Treatment Providers with support from the Center for Lawful Access and Abuse Deterrence and the American Society of Addiction Medicine.
Dr. Fudin is a reviewer for publications and poster submissions for the ACCP, American Society of Health-System Pharmacists, AAPM, and other recognized professional pharmacy, medical, and nursing organizations. He is founder and two-time past chair of the ACCP Pain Pharmacy Practice Network group.
Dr. Fudin is an active lecturer, writer, and researcher on pain management issues. He has been an invited speaker on pain management at VA Hospitals and at major academic medical centers throughout the United States. He is also the owner and managing editor of PainDr.com, and interactive website that houses his pain blog, which has many professional resources developed by Dr. Fudin for medical professionals including pharmacists.
Recent national attention to the Risk Evaluation and Mitigation Strategies (REMS) has been an increasing subject of interest. Dr. Fudin has been called upon by several professional organizations to help strategize in anticipation of much needed education on proper opioid prescribing and monitoring.
Practical Pain Management readers will recognize Dr. Fudin as one of the co-developers of the PPM Opioid Calculator.